PhiChem (300398) Fundamentals 2026 — P/E 46.5x, Revenue Analysis | SniperIQ
PhiChem (300398) is a CN-listed Basic Materials company in Chemicals - Specialty with a market capitalization of ¥19.4B, trading at ¥33.95 on the SHZ. This SniperIQ fundamentals page covers PhiChem's valuation (P/E 46.5x, P/B 3.8x), profitability (net margin 11.8%), revenue (¥3.2B in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.
Full research coverage
- 8-Quarter Revenue & Margin Trend
- Debt Maturity & Coverage
- Peer Valuation Comparison
- Free Cash Flow & Owner Earnings
- AI Signal + Institutional Flow
- DCF Valuation Model
Frequently Asked Questions
What is PhiChem's market cap?
PhiChem (300398) has a market capitalization of approximately ¥19.4B, trading at ¥33.95 on the SHZ. Market cap moves with the live share price.
What is PhiChem's P/E ratio?
PhiChem's trailing twelve-month P/E ratio is 46.5x, with a price-to-book (P/B) of 3.8x. Valuation multiples are best compared with Basic Materials sector peers rather than read in isolation.
How profitable is PhiChem?
PhiChem runs a net profit margin of 11.8%, a gross margin of 37.5%, and an operating margin of 15.0%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does PhiChem generate?
PhiChem reported revenue of ¥3.2B for fiscal year 2025, with net income of ¥390M and earnings per share (EPS) of 0.71. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.
Does PhiChem pay a dividend?
PhiChem offers a trailing dividend yield of about 0.3%. Dividend sustainability depends on payout ratio, free cash flow, and earnings stability — all tracked in SniperIQ's fundamentals view.
Is PhiChem financially healthy?
PhiChem carries a debt-to-equity ratio of 0.20x and a current ratio of 2.31x, with a market beta of 1.43. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is PhiChem a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For PhiChem (300398) the key facts are: market cap ¥19.4B, P/E 46.5x, revenue ¥3.2B, 52-week range 18.9-65.31. Weigh valuation, profitability, growth, and balance-sheet strength against Basic Materials peers and form your own view.
Track PhiChem's full fundamentals live
Get PhiChem's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.